EDBI seeks to generate long-term shareholder returns through our multidisciplinary investment team which encompasses experienced professionals in the fields of finance, science, engineering and medicine. We have a strong and wide-ranging   network with regional and global businesses, venture capital and private equity investment firms, and government agencies.

EDBI invests to create globally competitive and sustainable companies. As a premier investor in Asia, we lend our strengths to high growth companies in crafting and executing their internationalization strategies. Through our assistance, companies are able to establish activities in Singapore where the vibrant and dynamic business environment, and strong government support play key roles in fostering their future success.

Our capital and expertise help these companies broaden, deepen and sharpen their capabilities and access new sources of financing in private and public markets. As these companies adopt world-class standards, they become well positioned to globalize and become international market leaders.

EDBI also partners local and global multinational companies in their Singapore-based investments that have a substantial impact on industry development. We make strategic direct equity investments that allow our partners to strike the appropriate balance between risk and reward while accelerating their growth plans.

EDBI has been an active investor in enhancing and sustaining the strategic competitiveness of Singapore, one of the world's most vibrant economies.  EDBI currently holds stakes in diverse sectors spanning Biomedical Sciences, Chemicals, Electronics, Info Communications, Precision Engineering and Transport Engineering.  We have invested in over 240 companies since our inception.  Investments in our current portfolio include Chartered Silicon Partners, Chevron Phillips Singapore Chemicals, Lucasfilm Animation, Lonza Tuas, and S*Bio (a drug discovery and development company founded in Singapore).